We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-5.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.62B
AUM Growth
-$2.78B
Cap. Flow
-$2.47B
Cap. Flow %
-43.88%
Top 10 Hldgs %
56.27%
Holding
465
New
101
Increased
59
Reduced
84
Closed
204

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$44.1M
2
HRMY icon
Harmony Biosciences
HRMY
+$36.9M
3
TVTX icon
Travere Therapeutics
TVTX
+$33.9M
4
MDLN
Medline Inc
MDLN
+$22.4M
5
META icon
Meta Platforms (Facebook)
META
+$20.9M

Top Sells

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$70.6M
2
IMVT icon
Immunovant
IMVT
+$56.5M
3
XRAY icon
Dentsply Sirona
XRAY
+$53.6M
4
GEHC icon
GE HealthCare
GEHC
+$53.1M
5
PTCT icon
PTC Therapeutics
PTCT
+$51.5M

Sector Composition

Rank Sector Weight
1 Healthcare 38.27%
2 Technology 7.29%
3 Consumer Discretionary 4.25%
4 Communication Services 1.58%
5 Consumer Staples 1.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTLB icon
51
GitLab
GTLB
$5.53B
$22.3M 0.4%
1,028,664
+169,739
+20% +$4.96M
AUTL
52
Autolus Therapeutics
AUTL
$383M
$21.8M 0.39%
15,800,000
-1,700,000
-10% -$2.58M
S icon
53
CALL
SentinelOne
S
$6.71B
$21.3M 0.38%
1,650,000
-1,550,000
-48% -$21.5M
ANGO icon
54
AngioDynamics
ANGO
$558M
$21.3M 0.38%
1,869,000
+169,000
+10% +$1.83M
ARVN icon
55
Arvinas
ARVN
$517M
$21M 0.37%
1,978,000
+178,000
+10% +$2.2M
TSM icon
56
TSMC
TSM
$2.07T
$20.7M 0.37%
61,254
+11,254
+23% +$3.87M
ANRO icon
57
Alto Neuroscience
ANRO
$1.07B
$20.5M 0.36%
912,000
-624,000
-41% -$11.6M
ENR icon
58
Energizer
ENR
$1.39B
$19.7M 0.35%
1,200,000
+164,000
+16% +$3.32M
FIVN icon
59
CALL
FIVE9
FIVN
$1.96B
$19M 0.34%
1,250,000
-550,000
-31% -$9.56M
META icon
60
Meta Platforms (Facebook)
META
$1.64T
$18.6M 0.33%
+32,594
New +$20.9M
FDMT icon
61
4D Molecular Therapeutics
FDMT
$575M
$18.6M 0.33%
2,000,000
+64,000
+3% +$557K
MSFT icon
62
Microsoft
MSFT
$2.93T
$18.1M 0.32%
48,860
-69,477
-59% -$29.1M
EW icon
63
Edwards Lifesciences
EW
$49.4B
$18M 0.32%
224,835
-52,643
-19% -$4.34M
WYNN icon
64
Wynn Resorts
WYNN
$10B
$17.6M 0.31%
173,545
-2,645
-2% -$289K
MGNX icon
65
MacroGenics
MGNX
$285M
$17.4M 0.31%
6,012,000
-312,000
-5% -$665K
SRRK icon
66
Scholar Rock
SRRK
$6.33B
$16.6M 0.29%
336,959
+136,959
+68% +$6.14M
BCYC
67
Bicycle Therapeutics
BCYC
$294M
$15.8M 0.28%
3,398,000
+162,000
+5% +$926K
CENTA icon
68
Central Garden & Pet Co Class A
CENTA
$2.4B
$15.5M 0.28%
+478,000
New +$15.2M
LEN icon
69
Lennar Class A
LEN
$20.2B
$15.4M 0.27%
177,013
+25,718
+17% +$2.78M
TOST icon
70
Toast
TOST
$17.4B
$15.3M 0.27%
577,471
+349,718
+154% +$10.4M
SNY icon
71
Sanofi
SNY
$107B
$14.5M 0.26%
300,000
-376,000
-56% -$17.5M
BILL icon
72
BILL Holdings
BILL
$4.45B
$14.4M 0.26%
374,908
+103,519
+38% +$4.63M
PATH icon
73
UiPath
PATH
$6.3B
$14.3M 0.25%
1,284,720
-239,897
-16% -$3.05M
PENN icon
74
CALL
PENN Entertainment
PENN
$2.75B
$13.5M 0.24%
+900,000
New +$12.5M
VYGR icon
75
Voyager Therapeutics
VYGR
$192M
$13.5M 0.24%
3,500,000
-500,000
-13% -$1.97M
1 2
3
4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Armistice Capital held 465 positions worth $5.62B, down 33% from $8.4B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital withdrew a net $2.47B in Q1 2026, closing 204 positions and reducing 84 holdings. Its most notable exit was argenx, an estimated $48.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Armistice Capital opened a new position in UnitedHealth worth $40M.

  • Armistice Capital's largest Q1 2026 buy was UnitedHealth: 148,000 shares worth $40M.
  • Armistice Capital added most to Harmony Biosciences in Q1 2026, an estimated $36.9M increase.
  • Armistice Capital's biggest Q1 2026 reduction was Kenvue, cutting an estimated $70.6M.
  • Armistice Capital fully exited argenx in Q1 2026, selling an estimated $48.8M.
  • Armistice Capital's ten largest holdings make up 56% of its $5.62B portfolio in Q1 2026.
  • Armistice Capital opened 101 new positions and closed 204 in Q1 2026.
  • Armistice Capital's portfolio value fell 33% quarter-over-quarter to $5.62B.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.